omalizumab CRSwNP
Selected indexed studies
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. (J Allergy Clin Immunol, 2020) [PMID:32524991]
- Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. (Int Forum Allergy Rhinol, 2024) [PMID:37394893]
- Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. (Am J Rhinol Allergy, 2022) [PMID:35837739]
_Worker-drafted node — pending editorial review._
Connections
omalizumab CRSwNP is a side effect of
Sources
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. (2020) pubmed
- Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. (2022) pubmed
- Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. (2022) pubmed
- Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. (2025) pubmed
- Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. (2024) pubmed
- Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence. (2025) pubmed
- Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps. (2025) pubmed
- Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. (2024) pubmed
- B Lineage Cells and IgE in Allergic Rhinitis and CRSwNP and the Role of Omalizumab Treatment. (2023) pubmed
- Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study. (2023) pubmed